Morgan Stanley »

Briacell Therapeutics Corp shares owned by Morgan Stanley

Quarter-by-quarter ownership of Briacell Therapeutics Corp (BCTX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Briacell Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Briacell Therapeutics Corp held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Briacell Therapeutics Corp by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $13k 3.0k 4.19
2025-12-31 $25k 3.5k 7.11
2025-09-30 $1.3k 114 11.00

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Briacell Therapeutics Corp

Cable Car Capital
Iridian Asset Management
UBS Group
Morgan Stanley
Federation des caisses Desjardins du Quebec
Royal Bank of Canada
Hanson McClain Advisors
Ssa Swiss Advisors
TD Waterhouse Canada
Group One Trading
FNY Investment Advisers
Tower Research Capital
Caitong International Asset Management
HHM Wealth Advisors
Wells Fargo & Company

View all funds holding Briacell Therapeutics Corp